Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population is a research paper published in Transplantation and Cellular Therapy (2022). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart Lung and Blood Institute
Grant: 3OT3HL142480
National Heart Lung and Blood Institute
Grant: OT3HL147741
NHLBI NIH HHS
Grant: R38 HL167238
NHLBI NIH HHS
Grant: OT3 HL142480
National Institutes of Health
Grant: 3OT3HL142480-01S2
The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data Commons
National Institutes of Health
Grant: 3OT3HL147741-01S1
Cure Sickle Cell
National Institutes of Health
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals